The University of South Carolina has made changes to names and programs related to diversity, equity and inclusion amid ...

LIVEKIDNEY.BIO (LiveKidney), a clinical-stage biotech company developing cell-based therapies for kidney diseases, announced today that it has enrolled its first patient in a Phase I/IIa study of ...